{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:39:55Z","timestamp":1792517995623,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme United Kingdom","doi-asserted-by":"publisher","award":["192770"],"award-info":[{"award-number":["192770"]}],"id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck & Co Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015274","name":"Ministerio de Salud","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016344","name":"Ministry of Health and Population","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016344","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.vaccine.2026.128550","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:12:40Z","timestamp":1775520760000},"page":"128550","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["RSV ready? Exploring feasibility and acceptability of RSV immunization options in low- and middle-income countries"],"prefix":"10.1016","volume":"80","author":[{"given":"Manjari","family":"Quintanar-Solares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica A.","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilkister","family":"Musau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Mulati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surendra","family":"Uranw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla","family":"Kwarteng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10200","key":"10.1016\/j.vaccine.2026.128550_bb0005","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(19)30721-4","article-title":"Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study","volume":"394","author":"Pneumonia Etiology Research for Child Health (PERCH) Study Group","year":"2019","journal-title":"Lancet"},{"issue":"10340","key":"10.1016\/j.vaccine.2026.128550_bb0010","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis","volume":"399","author":"Li","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.128550_bb0015","first-page":"193","article-title":"WHO position paper on immunization to protect infants against respiratory syncytial virus disease, may 2025","volume":"100","author":"World Health Organization","year":"2025","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2026.128550_bb0020","series-title":"Highlights from the Meeting of the Strategic Advisory Group of Experts (SAGE) on Immunization 23\u201326 2024","author":"World Health Organization (WHO)","year":"2024"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128550_bb0025","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/AOG.0000000000005816","article-title":"Efficacy, safety, and immunogenicity of the MATISSE (maternal immunization study for safety and efficacy) maternal respiratory syncytial virus prefusion f protein vaccine trial","volume":"145","author":"Sim\u00f5es","year":"2025","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128550_bb0030","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S2352-4642(22)00321-2","volume":"7","author":"Sim\u00f5es","year":"2023","journal-title":"The Lancet Child & Adolescent Health"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128550_bb0035","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/jamapediatrics.2025.5778","article-title":"Effectiveness and impact of maternal RSV immunization and nirsevimab on medically attended RSV in US children","volume":"180","author":"Moline","year":"2026","journal-title":"JAMA Pediatr"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128550_bb0040","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S1473-3099(25)00233-6","article-title":"Effectiveness and impact of nirsevimab in Chile during the first season of a national immunisation strategy against RSV (NIRSE-CL): a retrospective observational study","volume":"25","author":"Torres","year":"2025","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128550_bb0045","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/INF.0000000000004878","article-title":"Maternal immunization with RSVpreF vaccine: effectiveness in preventing respiratory syncytial virus-associated hospitalizations in infants under 6 months in Argentina: Multicenter case-control study","volume":"44","author":"Gentile","year":"2025","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2026.128550_bb0050","series-title":"The Vaccine Alliance. Gavi Board focuses on health impact as priority guiding principle in a resource constrained world. 25 June","author":"Gavi","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128550_bb0055","series-title":"National Guidelines On Quality Obstetrics and Perinatal Care. MOH","author":"Kenya Ministry of Health (MOH)","year":"2022"},{"key":"10.1016\/j.vaccine.2026.128550_bb0060","series-title":"National Medical Standard for Maternal and Newborn Care. MOHP","author":"Nepal Ministry of Health and Population (MOHP)","year":"2020"},{"key":"10.1016\/j.vaccine.2026.128550_bb0065","series-title":"Norma T\u00e9cnica De Salud Para La Atenci\u00f3n Integral De Salud Materna\u2014NTS No. 105-MINSA\/DGSP-V.01 [Technical Health Standard for Comprehensive Maternal Health Care]","author":"Peru Ministry of Health (MOH)","year":"2013"},{"key":"10.1016\/j.vaccine.2026.128550_bb0070","series-title":"Linda Mama program","author":"Kenya National Health Insurance Fund","year":"2025"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128550_bb0075","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1186\/s12889-025-22897-9","article-title":"Inequalities in antenatal care service utilization in Nepal: evidence from nationally representative Nepal multiple indictor cluster surveys 2014 and 2019","volume":"25","author":"Sapkota","year":"2025","journal-title":"BMC Public Health"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128550_bb0080","article-title":"Antenatal care in Nepal: a qualitative study into missed opportunities in the first trimester","volume":"2","author":"Greenfield","year":"2022","journal-title":"AJOG Global Rep"},{"key":"10.1016\/j.vaccine.2026.128550_bb0085","series-title":"Nepal Safe Motherhood and Newborn Health Road Map 2030","author":"Nepal Ministry of Health and Population (MOHP), Family Welfare Division","year":"2019"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128550_bb0090","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1055\/s-0041-1732463","article-title":"Prevalence and determinants of adequate compliance with antenatal care in Peru","volume":"43","author":"Tello-Torres","year":"2021","journal-title":"Rev Bras Ginecol Obstet"},{"key":"10.1016\/j.vaccine.2026.128550_bb0095","series-title":"Kenya Demographic and Health Survey 2022: Key indicators report","author":"Kenya National Bureau of Statistics (KNBS) and ICF","year":"2023"},{"key":"10.1016\/j.vaccine.2026.128550_bb0100","series-title":"Annual Health Report 2079\/80","author":"Nepal Ministry of Health and Population (MOHP), Department of Health Services","year":"2024"},{"key":"10.1016\/j.vaccine.2026.128550_bb0105","series-title":"Protection at birth (PAB) against neonatal tetanus vaccination coverage and vaccination coverage among pregnant women of tetanus toxoid-containing vaccine (TT2+\/Td2+) and pertussis-containing vaccine\u2014Peru","author":"World Health Organization Immunization Data Portal","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128550_bb0110","series-title":"Influenza vaccination coverage\u2014pregnant women, Peru. Available from: https:\/\/immunizationdata.who.int\/global\/wiise-detail-page\/influenza-vaccination-coverage?CODE=PER&ANTIGEN=FLU_PW&YEAR=. Accessed 01 July","author":"World Health Organization Immunization Data Portal","year":"2025"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128550_bb0115","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2127561","article-title":"Lack of clear national policy guidance on COVID-19 vaccines influences behaviors in pregnant and lactating women in Kenya","volume":"18","author":"Zavala","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128550_bb0120","series-title":"Nepal. Available from: https:\/\/www.comitglobal.org\/country\/np. Accessed 01 July","author":"COVID-19 Maternal Immunization Tracker (COMIT)","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128550_bb0125","series-title":"Norma T\u00e9cnica de Salud que establece la vacunaci\u00f3n contra la COVID-19\u2014208-MINSA\/DGIESP-2023 [COVID-19 Vaccination Guideline]","author":"Peru Ministry of Health (MOH)","year":"2023"},{"key":"10.1016\/j.vaccine.2026.128550_bb0130","series-title":"Informe Preliminar Per\u00fa: Indicadores de Resultados de los Programas Presupuestales, Primer Semestre","author":"El Instituto Nacional de Estad\u00edstica e Inform\u00e1tica (INEI)","year":"2023"},{"key":"10.1016\/j.vaccine.2026.128550_bb0135","author":"Peru Ministry of Health","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128550_bb0140","series-title":"Vaccination schedule for tuberculosis for Nepal. Available at: https:\/\/immunizationdata.who.int\/global\/wiise-detail-page\/vaccination-schedule-for-tuberculosis?ISO_3_CODE=NPL&TARGETPOP_GENERAL=GENERAL. Accessed 01 July","author":"World Health Organization Immunization Data Portal","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128550_bb0145","series-title":"Norma T\u00e9cnica de Salud que establece el Esquema Nacional de Vacunaci\u00f3n\u2014141-MINSA\/2018\/DGIESP [National Immunization Guideline]. MOH; 2018. Available from: https:\/\/cdn.www.gob.pe\/uploads\/document\/file\/300034\/d177030_opt.PDF. Accessed 01 July","author":"Peru Ministry of Health (MOH)","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128550_bb0150","series-title":"Kenya: WHO and UNICEF estimates of immunization coverage: 2022 revision. Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/country-profiles\/immunization\/2023-country-profiles\/immunization_ken_2023.pdf. Accessed 01 July","author":"World Health Organization","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128550_bb0155","series-title":"Nepal: WHO and UNICEF estimates of immunization coverage: 2022 revision. Available from: https:\/\/cdn.who.int\/media\/docs\/default-source\/country-profiles\/immunization\/2023-country-profiles\/immunization_npl_2023.pdf. Accessed 01 July","author":"World Health Organization","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128550_bb0160","series-title":"Documento Tecnico: Plan de Implement Acion de Inmunizaciones en La Semana de Vacunacion en Las Americas \u2013 Minsa","author":"Peru Ministry of Health (MOH)","year":"2023"},{"key":"10.1016\/j.vaccine.2026.128550_bb0165","series-title":"Vaccination schedule for polio, by country","author":"World Health Organization Data Portal","year":"2025"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128550_bb0170","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2411823","article-title":"Facilitators and barriers to maternal immunization and strategies to improve uptake in low-income and lower-middle income countries: a systematic review","volume":"20","author":"Khan","year":"2024","journal-title":"Hum Vaccin Immunother"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128550_bb0175","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3390\/vaccines9080900","article-title":"COVID-19 vaccine hesitancy\u2014a scoping review of literature in high-income countries","volume":"9","author":"Aw","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128550_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0272273","article-title":"COVID-19 vaccine acceptance among pregnant women worldwide: a systematic review and meta-analysis","volume":"17","author":"Azami","year":"2022","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.vaccine.2026.128550_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0000628","article-title":"The impact of the COVID-19 pandemic on the uptake of routine maternal and infant vaccines globally: a systematic review","volume":"2","author":"Yunusa","year":"2022","journal-title":"PLOS Global Public Health"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128550_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0001332","article-title":"Barriers and facilitators to hepatitis b birth dose vaccination: perspectives from healthcare providers and pregnant women accessing antenatal care in Nigeria","volume":"3","author":"Freeland","year":"2023","journal-title":"PLOS Global Public Health"},{"key":"10.1016\/j.vaccine.2026.128550_bb0195","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.15475.1","article-title":"Maternal immunisation: what have been the gains? Where are the gaps? What does the future hold?","volume":"7","author":"Giles","year":"2018","journal-title":"F1000Res"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128550_bb0200","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1080\/21645515.2018.1564433","article-title":"Key considerations for successful implementation of maternal immunization programs in low and middle income countries","volume":"15","author":"Krishnaswamy","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128550_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2025.102680","article-title":"Cost-savings and health impact of strategies for prevention of respiratory syncytial virus with nirsevimab in Chile based on the integrated analysis of 2019-2023 national databases: a retrospective study","volume":"18","author":"Saur\u00e9","year":"2025","journal-title":"J Infect Public Health"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128550_bb0210","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S1473-3099(25)00156-2","volume":"25","author":"P\u00e9rez Marc","year":"2025","journal-title":"Lancet Infect Dis"},{"issue":"26","key":"10.1016\/j.vaccine.2026.128550_bb0215","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1016\/j.vaccine.2022.02.040","article-title":"WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants \u2013 key considerations for global use","volume":"40","author":"Sparrow","year":"2022","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26003580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26003580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:01:18Z","timestamp":1792515678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26003580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":43,"alternative-id":["S0264410X26003580"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128550","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RSV ready? Exploring feasibility and acceptability of RSV immunization options in low- and middle-income countries","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128550","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128550"}}